Pregabalin Capsule
Product Images NDC 60760-729

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 60760-729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60760-729 (Pregabalin 60760 729 60)

This text contains information about Pregabalin capsules with different strengths (100mg, 200mg), product details such as NDC code, lot number, expiration date, and manufacturer's address. It also includes directions for use, storage instructions, and mentions a pharmacy program. The product is recommended to be stored at controlled room temperature.*

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

FDA Label Image

Pregabalin-fig-a (Pregabalin Fig A)

This information appears to be related to a study or experiment involving a placebo and different dosages of a substance. The "Responder Rate (%)" is shown as 201%, with varying dosages listed for a placebo and another substance. The details seem to be incomplete and may require additional context for a clearer interpretation.*

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

This text seems to refer to the results of studies comparing different dosages of a treatment with a placebo. The study includes various dosage levels ranging from 50 mg/day to 600 mg/day and reports percentage outcomes for specific parameters. The results from Study E1 and Study E3 indicate a statistically significant difference compared to the placebo group. The text suggests a comparison of effectiveness between these dosages and a placebo in the study.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

This description pertains to the improvement of patients through different medications such as Pregabalin in varying dosages, along with a placebo. The text includes metrics suggesting the percentage of improvement in pain from the baseline.*

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

This text provides information on the percentage of patients who experienced improvement in pain with different doses of Pregabalin. The table shows the percentage of improvement in pain for various daily doses of Pregabalin, including 100mg, 450mg, and 300mg. Additionally, it indicates the percentage of patients improved from baseline pain levels. *

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.